Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 5—May 2005
THEME ISSUE
Dengue and Dengue Hemorrhagic Fever
Dengue and Dengue Hemorrhagic Fever

Dengue Antibody Prevalence in German Travelers

Ole Wichmann*Comments to Author , Annekathrin Lauschke*, Christina Frank†, Pei-Yun Shu‡, Matthias Niedrig†, Jyh-Hsiung Huang‡, Klaus Stark†, and Tomas Jelinek*
Author affiliations: *Berlin Institute of Tropical Medicine, Berlin, Germany; †Robert Koch Institute, Berlin, Germany; ‡Center for Disease Control, Taipei, Taiwan, Republic of China

Main Article

Table 1

Prevalence of anti-dengue antibodies in 2,255 patients according to travel destination and time*

Years No. acute infections/total no. travelers (%)
Southeast Asia and
Indian subcontinent Sub-Saharan Africa Latin America and
the Caribbean
1996–1998 22/491 (4.5) 2/309 (0.6) 4/271 (1.5)
2002–2004 25/529 (4.7) 3/376 (0.8) 8/279 (2.9)
Total 47/1,020 (4.6) 5/685 (0.7) 12/550 (2.2)

*Four patients are not included in this analysis since they traveled to >1 continent.

Main Article

Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external